These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 39337526)
21. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review. Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034 [TBL] [Abstract][Full Text] [Related]
22. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Shabbir U; Arshad MS; Sameen A; Oh DH Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988 [TBL] [Abstract][Full Text] [Related]
23. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care. Ciernikova S; Sevcikova A; Drgona L; Mego M Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728 [TBL] [Abstract][Full Text] [Related]
24. Influenza and the gut microbiota: A hidden therapeutic link. Luo C; Yang Y; Jiang C; Lv A; Zuo W; Ye Y; Ke J Heliyon; 2024 Sep; 10(18):e37661. PubMed ID: 39315196 [TBL] [Abstract][Full Text] [Related]
25. Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis. Chui ZSW; Chan LML; Zhang EWH; Liang S; Choi EPH; Lok KYW; Tun HM; Kwok JYY Sci Rep; 2024 Apr; 14(1):9558. PubMed ID: 38664425 [TBL] [Abstract][Full Text] [Related]
26. Understanding how pre- and probiotics affect the gut microbiome and metabolic health. Bock PM; Martins AF; Schaan BD Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E89-E102. PubMed ID: 38809510 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic strategies to modulate gut microbial health: Approaches for sarcopenia management. Das S; Preethi B; Kushwaha S; Shrivastava R Histol Histopathol; 2024 Nov; 39(11):1395-1425. PubMed ID: 38497338 [TBL] [Abstract][Full Text] [Related]
28. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans. Fabi JP Metab Brain Dis; 2024 Jun; 39(5):967-984. PubMed ID: 38848023 [TBL] [Abstract][Full Text] [Related]
29. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review. Moțățăianu A; Șerban G; Andone S Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894774 [TBL] [Abstract][Full Text] [Related]
30. Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment. Zhang R; Yan Z; Zhong H; Luo R; Liu W; Xiong S; Liu Q; Liu M Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967596 [TBL] [Abstract][Full Text] [Related]
31. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490 [TBL] [Abstract][Full Text] [Related]
32. Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights. Taghizadeh Ghassab F; Shamlou Mahmoudi F; Taheri Tinjani R; Emami Meibodi A; Zali MR; Yadegar A Life Sci; 2024 Aug; 350():122748. PubMed ID: 38843992 [TBL] [Abstract][Full Text] [Related]
33. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach. Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473 [TBL] [Abstract][Full Text] [Related]
34. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710 [TBL] [Abstract][Full Text] [Related]
35. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review. Baldi S; Mundula T; Nannini G; Amedei A World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163 [TBL] [Abstract][Full Text] [Related]
36. The Role of Prebiotics in Modulating Gut Microbiota: Implications for Human Health. Yoo S; Jung SC; Kwak K; Kim JS Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732060 [TBL] [Abstract][Full Text] [Related]
37. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease. Lim EY; Song EJ; Shin HS J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760 [TBL] [Abstract][Full Text] [Related]
38. Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism. Su SH; Wu YF; Lin Q; Zhang L; Wang DP; Hai J J Neuroinflammation; 2022 Dec; 19(1):313. PubMed ID: 36567333 [TBL] [Abstract][Full Text] [Related]
39. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238 [TBL] [Abstract][Full Text] [Related]
40. The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective. Lin X; Han H; Wang N; Wang C; Qi M; Wang J; Liu G Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]